Dr. Brian Waihun Chou, MD

Dr. Chou practices at Harborview Medical Center in Seattle, Washington, part of University of Washington.

Dr. Chou's NPI, 1467844233, was assigned on March 3, 2015. Dr. Chou graduated from Loma Linda University School Of Medicine in 2018. Dr. Chou holds Washington license MD61393766.

Dr. Chou's primary practice is Harborview Medical Center, at 325 9th Avenue, Seattle, WA 98104 in King County. The practice phone is (206) 744-9535.

Dr. Chou's primary practice is Harborview Medical Center in Seattle, Washington, part of University of Washington. Dr. Chou is also affiliated with UW Medical Center - Montlake. The medical group on file is UW Physicians. Dmand AI also links Dr. Chou to 2 more hospitals, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Chou practices, 4 sites in all. Vendor and product names are available with a free account.

Ophthalmology is Dr. Chou's primary specialty in the NPI Registry, under taxonomy code 207W00000X. Dr. Chou is board certified in ophthalmology by the American Board of Ophthalmology. Dmand AI has Dr. Chou's licenses on file in 4 states: Washington, Arizona, California and Illinois.

CMS data shows 403 Medicare services from Dr. Chou across 10 procedure codes in 2024, for 169 Medicare patients. Medicare paid $20,311 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 169 Medicare patients who saw Dr. Chou in 2024. The largest group is 65 to 74, with 73 patients. 70% of them have high cholesterol, and 69% have high blood pressure. 17% are also on Medicaid. Their average risk score is 1.72, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Chou's median patient age at 55, with 59% women.

In 2024, Dr. Chou wrote 89 Medicare Part D claims for 36 patients. 49% of them were for generic drugs. CMS names the drug for 33 of them, across 2 drugs with 11 or more claims each, at $19,204 in total drug cost. In 2023, CMS named 11 claims across 1 drug.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 94 out of 100 for Dr. Chou for performance year 2024, reported through an alternative payment model (APM). Dr. Chou accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Cataract surgery: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 11 papers to Dr. Chou, published from 2013 to 2024. 2013 was the busiest year, with 3. The most frequent topics are Plasmids, Transfection and DNA. Dr. Chou has published most often in Orbit. Dr. Chou's most frequent co-authors are Courtney Erin Francis, MD, Ersilia Anghel, MD and David Alan Bush, MD.

CMS Open Payments shows 3 general payments to Dr. Chou from 3 drug and device companies from 2021 to 2025. Food and beverage make up the largest share, 100% of the total. Alcon Laboratories Inc paid the most, $116.

Dr. Chou graduated from Loma Linda University School Of Medicine in 2018.

Dr. Chou is in network with 17 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. PPO plans come from the most carriers, 11. Check the plan with the practice before a visit.